Furthermore, investigators have reported that TLR2 stimulation can induce Th2 immunity [34,35], which is the prominent immunity of chronic GVHD, whereas TLR9 stimulation promotes Th1 immune responses, the characterized immunity of acute GVHD [35]. This evidence concerns the gene TLR2 and acute graft versus host disease.